MolecuLight Unveils Thermal Imaging for DX™ Platform, Delivering Measurement, Bacterial & Thermal Assessment in One Device, and Showcases Clinical Evidence at SAWC Spring

April 30, 2025 -

Toronto, Canada – April 30, 2025 – MolecuLight Inc., a global pioneer in point-of-care fluorescence imaging for rapid detection of infection causing bacteria in wounds, today announced the immediate availability of its new Thermal Imaging Module for the MolecuLightDX™ fluorescence imaging platform. This innovative clip-on module allows

… Read More

MolecuLight Showcases Advanced Wound Care Imaging at 2025 CAMPS Meeting

February 28, 2025 -

Pittsburgh, PA – 2/28/2025 – MolecuLight Inc., the leader in point-of-care fluorescence imaging devices for wound care, is excited to announce its participation in the 2025 Cellular, Acellular, and Matrix-like Products (CAMPs) Wound Care Summit, held from February 28th to March 2nd in Fort Lauderdale, Florida. In

… Read More

MolecuLight Announces Presentation of its Clinical and Surgical Benefits in Reconstructive Plastic Surgery by Dr. Michael Desvigne at the 47th Annual JAB Maui Burn & Wound Symposium

January 28, 2025 -

Toronto, CANADA – January 28th, 2025 – MolecuLight Corp., a leader in point-of-care fluorescence imaging for wound care, is excited to announce that Dr. Michael N. Desvigne, a renowned board-certified plastic surgeon and wound care clinician, will present the clinical and surgical benefits of MolecuLight’s fluorescence imaging

… Read More